International Assets Investment Management LLC Trims Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

International Assets Investment Management LLC lessened its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 99.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,487 shares of the company's stock after selling 615,426 shares during the period. International Assets Investment Management LLC's holdings in GE HealthCare Technologies were worth $508,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Private Advisor Group LLC lifted its stake in shares of GE HealthCare Technologies by 1.9% in the 2nd quarter. Private Advisor Group LLC now owns 27,428 shares of the company's stock worth $2,137,000 after acquiring an additional 518 shares during the period. Acadian Asset Management LLC purchased a new stake in GE HealthCare Technologies in the 2nd quarter valued at approximately $629,000. Quest Partners LLC acquired a new position in GE HealthCare Technologies during the 2nd quarter worth approximately $95,000. Ashton Thomas Private Wealth LLC purchased a new position in shares of GE HealthCare Technologies during the 2nd quarter worth approximately $49,000. Finally, Royal London Asset Management Ltd. lifted its holdings in shares of GE HealthCare Technologies by 2.3% in the 2nd quarter. Royal London Asset Management Ltd. now owns 171,635 shares of the company's stock valued at $13,374,000 after buying an additional 3,862 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

Shares of GEHC traded down $1.50 during mid-day trading on Friday, reaching $84.76. 3,791,919 shares of the company's stock were exchanged, compared to its average volume of 3,454,140. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. GE HealthCare Technologies Inc. has a 52-week low of $71.31 and a 52-week high of $94.55. The company has a market cap of $38.72 billion, a price-to-earnings ratio of 23.29, a PEG ratio of 2.90 and a beta of 1.11. The company has a 50-day simple moving average of $82.25 and a two-hundred day simple moving average of $84.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. During the same quarter last year, the business posted $0.99 earnings per share. GE HealthCare Technologies's revenue was up .9% compared to the same quarter last year. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. This is a positive change from GE HealthCare Technologies's previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies's dividend payout ratio is 3.85%.

Analysts Set New Price Targets

GEHC has been the topic of a number of recent analyst reports. Evercore ISI upped their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a report on Tuesday, October 1st. Stifel Nicolaus upped their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a "buy" rating in a research note on Monday, September 30th. Wells Fargo & Company increased their price target on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a report on Thursday, October 31st. BTIG Research raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 price objective on the stock in a report on Wednesday, September 18th. Finally, UBS Group lowered shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and lowered their target price for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. One analyst has rated the stock with a sell rating, four have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $96.00.

Insiders Place Their Bets

In related news, CEO Roland Rott sold 3,577 shares of the company's stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares of the company's stock, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.27% of the stock is owned by corporate insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.